SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013359
Filing Date
2020-11-09
Accepted
2020-11-09 16:12:34
Documents
66
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20200930x10q.htm   iXBRL 10-Q 1488267
2 EX-10.1 omer-20200930xex10d1.htm EX-10.1 46534
3 EX-31.1 omer-20200930xex31d1.htm EX-31.1 11339
4 EX-31.2 omer-20200930xex31d2.htm EX-31.2 12526
5 EX-32.1 omer-20200930xex32d1.htm EX-32.1 8117
6 EX-32.2 omer-20200930xex32d2.htm EX-32.2 7663
7 GRAPHIC omer-20200930x10q006.jpg GRAPHIC 34875
  Complete submission text file 0001558370-20-013359.txt   6993654

Data Files

Seq Description Document Type Size
8 EX-101.SCH omer-20200930.xsd EX-101.SCH 39806
9 EX-101.CAL omer-20200930_cal.xml EX-101.CAL 61993
10 EX-101.DEF omer-20200930_def.xml EX-101.DEF 125187
11 EX-101.LAB omer-20200930_lab.xml EX-101.LAB 410413
12 EX-101.PRE omer-20200930_pre.xml EX-101.PRE 294355
13 EXTRACTED XBRL INSTANCE DOCUMENT omer-20200930x10q_htm.xml XML 1498403
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 201297817
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences